1394 J ournal of Medicinal Chemistry, 2001, Vol. 44, No. 9
Marquis et al.
W. W.; Abdel-Meguid, S. S.; D’Alessio, K.; J anson, C. A.;
McQueney, M. S.; Tomaszek, T. A.; Levy, M. A.; Veber, D. F.
Use of X-ray co-rystal structures and molecular modeling to
design potent and selective non-peptide inhibitors of cathepsin
K. J . Am. Chem. Soc. 1998, 35, 9114-9115. (c) LaLonde, J . M.;
Zhao, B.; Smith, W. W.; J anson, C. A.; DesJ arlais, R. L.;
Tomaszek, T. A.; Carr, T. J .; Thompson, S. K.; Oh, H.-J .;
Yamashita, D. S.; Veber, D. F.; Abdel-Meguid, S. S. Use of papain
(17) (a) Yamashita, D. S.; Dong, X.; Oh, H.-J .; Brook, C. S.; Tomaszek,
T. A.; Szewczuk, L.; Tew, D. G.; Veber, D. F. Solid-phase
synthesis of
a combinatorial array of 1,3-bis(acylamino)-2-
butanones, inhibitors of the cysteine proteases cathepsins K and
L. J . Comb. Chem. 1999, 1, 207-215.
(18) Greenlee, W. J .; Springer, J . P.; Patchett, A. A. Synthesis of an
analogue of tabtoxinine as a potential inhibitor of D-alanine:
D-ligase (ADP forming). J . Med. Chem. 1989, 32, 165-170.
(19) Albeck, A.; Persky, R. Stereocontrolled synthesis of erythro
N-protected R-amino epoxides and peptidyl epoxides. Tetrahe-
dron 1994, 50, 6333-6346.
as
a model for the structure-based design of cathepsin K
inhibitors: Crystal structures of two papain-inhibitor complexes
demonstrate binding to S′-subsites. J . Med. Chem. 1998, 41,
4567-4576.
(20) (a) Liskamp, R. M. J . Conformationally restricted amino acids
and dipeptides, (non)peptidomimetics and secondary structure
mimetics. Recl. Trav. Chim. Pays-Bas, 1994, 113, 1-19. (b)
Marshall, G. R.; Fedric, G. A.; Moore, M. L. Peptide conformation
and biological activity. Annu. Rep. Med. Chem. 1978, 13, 227.
(21) J ames, I. E.; Lark, M. W.; Zembryki, D.; Lee-Rykaczewski, E.
V.; Hwang, S. M.; Tomaszek, T. A.; Belfiore, P. Gowen, M.
Development and characterization of a human in vitro resorption
assay: demonstration of utility using novel antiresorptive
agents. J . Bone Miner. Res. 1999, 14, 1562-1569.
(7) Veber, D. F.; Yamashita, D. S.; Oh, H.-J .; Smith, B. R.; Salyers,
K.; Levy, M.; Lee, C.-P.; Marzulli, A.; Smith, P. L.; Tomaszek,
T.; Tew, D.; McQueney, M.; Stroup, G. B.; Lark, M. W.; J ames,
I. E.; Gowen, M. Novel inhibitors of the osteoclast specific
cysteine protease, cathepsin K. Pept. New Millenium, Proc. Am.
Pept. Symp., 16th 2000, 453-455.
(8) Marquis, R. W.; Yamashita, D. S.; Ru, Y.; LoCastro, S. M.; Oh,
H.-J .; Erhard, K. F.; DesJ arlais, R. L.; Head, M. S.; Smith, W.
W.; Zhao, B.; J anson, C. A.; Abdel-Meguid, S. S.; Tomaszek, T.
A.; Levy, M. A.; Veber, D. F. Conformationally constrained 1,3-
diaminoketones: a series of potent and selective inhibitors of
the cysteine protease cathepsin K. J . Med. Chem. 1998, 41,
3563-3567.
(9) Marquis, R. W.; Ru, Y.; Zeng., J .; Trout, R. E. L.; LoCastro, S.
M.; Gribble, A. D.; Witherington, J .; Fenwick, A. E.; Garnier,
B.; Tomaszek, T. A.; Tew, D.; Hemling, M. E.; Quinn, C. J .;
Smith, W. W.; J anson, C. A.; Zhao, B.; McQueney, M. S.;
D’Alessio, K. J .; Veber, D. F. Cyclic ketone inhibitors of the
cysteine protease cathepsin K. J . Med. Chem. 2001, 44, 725-
736.
(22) Dodds, R. A.; J ames, I. E.; Rieman, D.; Hwang, S.-M.; Ahern,
R.; Connor, J . R.; Thompson, S.; Veber, D.; Drake, F. H.; Holmes,
S.; Lark, M. W.; Gowen, M. Human osteoclast cathepsin K is
processed intracellularly prior to attachment and bone resorp-
tion. J . Bone Miner. Res. 2001, 16, 478-486.
(23) The synthesis of deuterated analogues 37 and 38 is shown below:
(10) Marquis, R. W.; Ru, Y.; Erhard, K. F.; Gribble, A. D.; Wither-
ington, J .; Fenwick, A.; Garnier, B.; Bradbeer, J .; Lark, M.;
Gowen, M.; Tomaszek, T. A.; Tew, D. G.; Zhao, B.; Smith, W.
W.; J anson, C. A.; D’Alessio, K. J .; McQueney, M. S.; Abdel-
Meguid, S. S.; Salyers, K. L.; Smith, B. R.; Levy, M. A.; Veber,
D. F. Orally bioavailable inhibitors of the cysteine protease
cathepsin K. 218th ACS National Meeting, New Orleans, LA,
Aug 22-26, 1999; MEDI-019.
(11) As examples:
(24) McQueney, M. S.; Feild, J .; Hanning, C. R.; Brun, K.; Ram-
achandran, K.; Connor, J .; Drake, F.; J ones, C. S.; Amegadzie,
B. Y. Cynomolgus monkey (Macaca fascicularis) cathepsin K:
cloning, expression, purification and activation. Protein Express.
Purif. 1998, 14, 7-394.
(25) Feild, J .; Brun, K.; Hanning, C. R.; Tomaszek, T.; Amedgadzie,
B.; D’Alessio, K. J .; Yamashita, D. S.; Oh, H.-J .; Veber, D. F.;
Lark, M. W.; McQueney, M. Characterization of rat cathepsin
K. Submitted for publication.
(26) Stroup, G. B.; Lark, M.; Veber, D. F.; Bhattacharyya, A.; Blake,
S.; Dare, L. C.; Erhard, K. F.; Hoffman, S. J .; J ames, I. E.;
Marquis, R. W.; Ru, Y.; Vasko-Moser, J . A.; Smith, B. R.;
Tomaszek, T.; Gowen, M. Potent and selective inhibition of
cathepsin K leads to inhibition of bone resorption in vivo in a
nonhuman primate. Submitted for publication.
(27) Lark, M. W.; Stroup, G. B.; J ames, I. A.; Dodds, R. A.; Hwang,
S.-M.; Blake, S. M.; Lechowska, B. A.; Hoffman, S. J .; Smith, B.
R.; Kapadia, R.; Erhard, K.; Ru, Y.; Dong, X.; Marquis, R. W.;
Veber, D.; Gowen, M. Inhibition of cathepsin K with the small
molecule, nonpeptidic inhibitor SB-331750, prevents bone matrix
resorption in the ovariectomized rat. Submitted for publication.
(28) Ring conformation and relative positions of the proximal pendant
groups were analyzed by modeling both diastereomers of the
representative thiohemiketal 39:
(12) De Amici, M.; De Micheli, C.; Misani, V. Nitrile oxides in
medicinal chemistry-2. Synthesis of the two diastereomers of
dihydromuscimol. Tetrahedron 1990, 46, 1975-1986.
(13) (a) Nguyen, S. T.; J ohnson, L. K.; Grubbs, R. H.; Ziller, J . W.
Ring-opening metathesis polymerization (ROMP) of polystyrene
by group VIII carbene complex in protic media. J . Am. Chem.
Soc. 1992, 114, 3974-3975. (b) Fu, G. C.; Grubbs, R. H. The
application of catalytic ring-closing olefin metathesis to the
synthesis of unsaturated oxygen heterocycles. J . Am. Chem. Soc.
1992, 114, 5426-5427. (c) Miller, S. J .; Kim, S.-H.; Chen, Z.-R.;
Grubbs, R. H. Catalytic ring-closing metathesis of dienes:
application to the synthesis of eight-membered rings. J . Am.
Chem. Soc. 1995, 117, 2108-2109. (d) Miller, S. J .; Grubbs, R.
H. Synthesis of conformationally restricted amino acids and
peptides employing olefin metathesis. J . Am. Chem. Soc. 1995,
117, 5855-5856. (e) Grubbs, R. H.; Chang, S. Recent advances
in olefin metathesis and its application in organic synthesis.
Tetrahedron 1998, 54, 4413-4450.
(14) For a discussion of the factors influencing the nucleophilic ring
opening of the 8-oxa-3-azabicyclo[5.1.0]octane ring system, see:
(a) Tanner, D.; Almario, A.; Ho¨gberg, T. Total synthesis of
balanol, part 1. Enantioselective synthesis of the hexahy-
droazepine ring via chiral epoxides and aziridines. Tetrahedron
1995, 51, 6061-6070, (b) Tanner, D.; Tedenborg, L.; Almario,
A.; Petterson, I.; Cso¨regh, I.; Kelly, N. M.; Anderson, P. G.;
Ho¨gberg, T. Total synthesis of balanol 2. Completion of the
synthesis and investigation of the structure and reactivity of two
key heterocyclic intermediates. Tetrahedron 1997, 53, 4857-
4868.
(15) Bayley, H.; Standring, D. N.; Knowles, J . R. Propane-1,3-
dithiol: a selective reagent for the efficient reduction of alkyl
and aryl azides to amines. Tetrahedron Lett. 1978, 39, 3633-
3634.
(16) Parikh, J . R.; Doering, v. W. E.; Sulfur trioxide in the oxidation
of alcohols by dimethyl sulfoxide. J . Am. Chem. Soc. 1967, 89,
5505.
(29) Hunter, C. A.; Sanders, J . K. M. The nature of π-π interactions.
J . Am. Chem. Soc. 1990, 112, 5525-5534.
(30) (a) Smith, A. B., III; Guzman, M. C.; Sprengler, P A.; Keenan,
T. P.; Holcomb, R. C.; Wood, J . L.; Carroll, P. J .; Hirschmann,
R. De novo design, synthesis and X-ray crystal structures of the
pyrrolidinone-based â-strand peptidomimetics. J . Am. Chem.
Soc. 1994, 116, 9947-9962; see also refs 9 and 10 of this article.
(b) Smith, A. B., III; Keenan, T. P.; Holcomb, R. C.; Sprengler,
P. A.; Guzman, M. C.; Wood, J . L.; Carroll, P. J .; Hirschman, R.
J . Am. Chem. Soc. 1992, 114, 10672-10674. (c) Fairlie, D. P.;
Tyndall, J . D. A.; Reid, R. C.; Wong, A. K.; Abbenante, G.;
Scanlon, M. J .; March, D. R.; Bergman, D. A.; Chai, C. L. L.;
Burkett, B. A. J . Med. Chem. 2000, 43, 1271-1281.